Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.00 (0.00%)
Bid:
22.00
Ask:
23.00
Spread: 1.00 (4.545%)
Market Cap: £20.17m
IHC Live PriceLast checked at - London Stock Exchange

Intraday Inspiration Hlt Share Chart

Director/PDMR Shareholding

24 Sep 2019 10:09

RNS Number : 4502N
Inspiration Healthcare Group PLC
24 September 2019
 

24 September 2019

Inspiration Healthcare Group plc

("Inspiration Healthcare" or the "Company")

Director/PDMR Shareholding

Further to the Company's announcements on 5 September 2019 and 23 September 2019, Inspiration Healthcare announces that certain Directors have, following Admission today, acquired a total of 154,693 ordinary shares of 10 pence each in the Company ("Ordinary Shares") via the Placing as detailed below:

Name

Number of Placing Shares subscribed for

Value of Placing Shares subscribed for

Resultant shareholding following subscription in the Placing

Percentage of enlarged share capital following proposed subscription

Mark Abrahams

Non-executive Chairman

86,047

£49,907.26

241,201

0.6%

Mike Briant

Chief Financial Officer

34,323

£19,907.34

34,323

0.1%

Brook Nolson

Non-executive Director

34,323

£19,907.34

34,323

0.1%

Total

154,693

£89,721.94

309,847

0.8%

 

Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the circular sent to shareholders of the Company on 5 September 2019.

 

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Mark Abrahams

2. Mike Briant

3. Brook Nolson 

2

Reason for the notification

a)

 

Position/status

 

1. Non-executive Chairman

2. Chief Financial Officer

3. Non-executive Director

b)

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Inspiration Healthcare Group plc

b)

LEI

213800GKFT3ENAPMDL15

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10 pence each

 

ISIN: GB00BXDZL105

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1. 58 pence

2. 58 pence

3. 58 pence

1. 86,047

2. 34,323

3. 34,323

d)

Aggregated information

- Aggregated volume

- Price

 

N/A - single transaction

e)

Date of the transaction

24 September 2019

f)

Place of the transaction

London Stock Exchange, XLON

 

Enquiries:

Inspiration Healthcare Group plcNeil Campbell, Chief Executive OfficerMike Briant, Chief Financial Officer

Tel: 01455 840555

 

Cenkos Securities plc - Nominated Adviser & BrokerStephen Keys / Cameron MacRitchie

Tel: 0207 397 8900

 

Cadogan PRAlex Waltersalex.walters@cadoganpr.com

Tel: 07771 713608

 

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies. 

Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally the Company has its own range of products for maintaining normothermia pre- during and post-surgery.

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLIFIAADISFIA
Date   Source Headline
16th Jun 20267:00 amRNSFinal Results
2nd Jun 20267:01 amRNSNotice of Results
2nd Jun 20267:00 amRNSTransfer of Non-Core Products to Focus on Neonatal
14th Apr 20267:00 amRNSChange of Adviser
16th Mar 20269:33 amRNSHolding(s) in Company
16th Mar 20269:33 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSUK neonatal division wins NHS framework agreement
26th Feb 20269:23 amRNSHolding(s) in Company
12th Feb 20267:00 amRNSFull year trading update
10th Feb 20269:05 amRNSHolding(s) in Company
3rd Feb 20267:00 amRNSAppointment of Joint Broker
2nd Feb 202611:01 amRNSHolding(s) in Company
28th Jan 20261:40 pmRNSHolding(s) in Company
28th Jan 20267:00 amRNSPurchasing agreement in the US
27th Jan 20269:46 amRNSHolding(s) in Company
26th Jan 202610:02 amRNSHolding(s) in Company
22nd Jan 20261:37 pmRNSHolding(s) in Company
26th Nov 20257:00 amRNSChange of auditor
16th Oct 20251:51 pmRNSHolding(s) in Company
7th Oct 20257:00 amRNSHalf-year Report
23rd Sep 20257:00 amRNSResults presentations for analysts and investors
19th Sep 20257:00 amRNSDirectorate Change
20th Aug 20257:00 amRNSTrading update and notice of results
24th Jul 20251:37 pmRNSResult of AGM
24th Jul 20257:00 amRNSAGM Statement
13th Jun 20259:16 amRNSPublication of AR, accounts & notice of AGM
6th Jun 20257:00 amRNSBoard Change
28th May 20257:00 amRNSUnaudited Preliminary results
23rd May 20257:00 amRNSNotice of Results
15th May 20255:01 pmRNSHolding(s) in Company
15th May 202510:06 amRNSHolding(s) in Company
1st Apr 202511:36 amRNSHolding(s) in Company
21st Mar 20252:49 pmRNSGrant of Options
12th Mar 20256:01 pmRNSHolding(s) in Company
12th Mar 20256:00 pmRNSDirector/PDMR Shareholding
24th Feb 20254:16 pmRNSDirector/PDMR Shareholding
21st Feb 20252:52 pmRNSDirector/PDMR Shareholding
18th Feb 20257:00 amRNSTrading update
10th Feb 20259:54 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSDirectorate Change
14th Jan 20254:08 pmRNSHolding(s) in Company
12th Dec 20247:00 amRNSAppointment of Chief Executive Officer
14th Nov 20247:00 amRNSBoard Change
4th Nov 20247:00 amRNSGrant of Covenant Waiver and Covenant Reset
2nd Oct 20247:00 amRNSHalf-year Report
17th Sep 202412:26 pmRNSResult of AGM
3rd Sep 20247:00 amRNSTrading update for the six months to 31 July 2024
5th Aug 20243:41 pmRNSHolding(s) in Company
2nd Aug 20247:00 amRNSNominated adviser and broker
31st Jul 20243:29 pmRNSPublication of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.